semaglutide north carolina NCSHP will tighten coverage of Ozempic, other diabetes drugs NC Medicaid to cover weight-loss

Research indicates that some weight regain is common when treatment stops

If the injection feels different, stings more than usual, or produces unusual redness at the site, the solution composition may have changed

Despite the difference in dosing frequency, a study published in the journal Diabetes Care found that both of these medications were equally effective in reducing HbA1c levels, and there was no significant difference in weight loss between the two groups

Some patients also reported moderate-to-mild urinary tract infection or skin discomfort

The FDA approved Ozempic specifically for treating type 2 diabetes in adults